Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development-Reference-Cited by-同舟云学术

Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development

Published:2007-10 Issue:10 Volume:8 Page:933-939
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Hsieh Andrew C,Small Eric J,Ryan Charles J

Publisher

Elsevier BV

Subject

Oncology

Reference76 articles.

1. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance;Holzbeierlein;Am J Pathol,2004

2. Evolution of the androgen receptor pathway during progression of prostate cancer;Hendriksen;Cancer Res,2006

3. The program of androgen-responsive genes in neoplastic prostate epithelium;Nelson;Proc Natl Acad Sci USA,2002

4. cDNA microarray analysis identifies genes induced in common by peptide growth factors and androgen in human prostate epithelial cells;York;Mol Carcinog,2005

5. Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse;Henshall;Cancer Res,2003

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canonical AREs are tumor suppressive regulatory elements in the prostate;2024-02-27

2. Oligo-benzamide-based peptide mimicking tools for modulating biology;Methods in Enzymology;2024

3. Autocrine proteinase-activated receptor signaling in PC3 prostate cancer cells;American Journal of Physiology-Cell Physiology;2023-07-01

4. PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal;Current Medicinal Chemistry;2023-06-07

5. FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer;Cancer Letters;2022-02